Denny Muha

Role: Head of Human Resources at Capsida Biotherapeutics
Location: Los Angeles, CA, US
LinkedIn followers: 500 followers

Human ResourcesView LinkedIn profile

About Denny Muha

I\'m a pragmatic, solutions-oriented HR leader with a track record of aligning people…

Experience

Head of Human Resources
Capsida Biotherapeutics
May 2021 — Present

Education

University of Illinois Urbana-Champaign
Master's degree , Human Resources and Industrial Relations
2007 — 2009
University of Illinois Urbana-Champaign
Bachelor of Science - BS, Applied Health Scien
2004 — 2007

Skills

Peoplesoft
Organizational Development
Personnel Management
Training
Program Management
Process Improvement
Deferred Compensation
Recruiting
Leadership
Interviews
Onboarding
Employee Engagement
Change Management
Project Management
Executive Pay
Succession Planning
Employee Relations
Human Resources
Leadership Development
Talent Management
Policy
Performance Management
Hris

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@capsida.com
Personal email
•••••@•••••.com
Direct dial
+12•••••••61

Unlock verified contacts

Free to start · No credit card required

Current company

Capsida Biotherapeutics

Biotechnology · 43 employees · Founded 2019 · Newbury Park, California, United States

Capsida Biotherapeutics Inc. is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening genetic disorders. Capsida\'s technology allows for the targeted penetration of cells and organs, while limiting collateral impact on non-targeted cells and organs, especially the liver. This technology allows for the delivery of the gene therapy in a non-invasive way through intravenous administration. Capsida\'s technology is protected by a growing intellectual property portfolio which includes more than 30 patent applications and one issued U.S. patent 11,149,256. The company is exploring using the technology across a broad range of life-threatening genetic disorders. Its initial pipeline consists of multiple neurologic disease programs. The company has strategic collaborations with AbbVie and CRISPR, which provide independent validation of Capsida\'s technology and capabilities. Capsida is a multi-functional and fully integrated biotechnology company with proprietary adeno-associated virus (AAV) engineering, multi-modality cargo development and optimization, translational biology, process development and state-of-the-art manufacturing, and broad clinical development experience. Capsida\'s biologically driven, high-throughput AAV engineering and cargo optimization platform originated from groundbreaking research in the laboratory of Viviana Gradinaru, Ph.D, a neuroscience professor at the California Institute of Technology.

capsida.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.